[
  {
    "ts": null,
    "headline": "Is AbbVie Inc. (ABBV) the Best Pharma Dividend Stock to Buy In 2024?",
    "summary": "We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower […]",
    "url": "https://finnhub.io/api/news?id=89ecf8f6e4ada9a0cf0bfbe453a94acaae281ef8d51165cc8d3a01c84e57340e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735597078,
      "headline": "Is AbbVie Inc. (ABBV) the Best Pharma Dividend Stock to Buy In 2024?",
      "id": 132208960,
      "image": "https://s.yimg.com/ny/api/res/1.2/m1YYSOl9HO_x0LHuYGlC8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower […]",
      "url": "https://finnhub.io/api/news?id=89ecf8f6e4ada9a0cf0bfbe453a94acaae281ef8d51165cc8d3a01c84e57340e"
    }
  },
  {
    "ts": null,
    "headline": "Is AbbVie Inc. (ABBV) the Best Stock for 10 Years?",
    "summary": "We recently compiled a list of the Long-Term Stock Portfolio: Best Stocks for 10 Years. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other long-term stocks. To select stocks with long-term growth potential, investors should focus on fundamental analysis, evaluating financial health through earnings history, revenue […]",
    "url": "https://finnhub.io/api/news?id=679385931e3ed921893b27a23e7d2ce6e5a020e2431183c4bdcbdd88b530cf77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735585833,
      "headline": "Is AbbVie Inc. (ABBV) the Best Stock for 10 Years?",
      "id": 132204936,
      "image": "https://s.yimg.com/ny/api/res/1.2/m1YYSOl9HO_x0LHuYGlC8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the Long-Term Stock Portfolio: Best Stocks for 10 Years. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other long-term stocks. To select stocks with long-term growth potential, investors should focus on fundamental analysis, evaluating financial health through earnings history, revenue […]",
      "url": "https://finnhub.io/api/news?id=679385931e3ed921893b27a23e7d2ce6e5a020e2431183c4bdcbdd88b530cf77"
    }
  },
  {
    "ts": null,
    "headline": "BOE: Losing Its Attraction For Anyone Seeking International Diversification",
    "summary": "Investors seeking high yield with equity exposure may consider BlackRock Enhanced Global Dividend Trust, despite sustainability concerns. Click for my BOE update.",
    "url": "https://finnhub.io/api/news?id=bea2d4f28cb93b47c0482405b7fb312312412ed40f7888fe242f5b5295d1fcfe",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735576185,
      "headline": "BOE: Losing Its Attraction For Anyone Seeking International Diversification",
      "id": 132206008,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1567445633/image_1567445633.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Investors seeking high yield with equity exposure may consider BlackRock Enhanced Global Dividend Trust, despite sustainability concerns. Click for my BOE update.",
      "url": "https://finnhub.io/api/news?id=bea2d4f28cb93b47c0482405b7fb312312412ed40f7888fe242f5b5295d1fcfe"
    }
  },
  {
    "ts": null,
    "headline": "Credit Spreads Haven’t Looked This Good Since the 2000s. Can They Get Better?",
    "summary": "Companies took advantage of favorable financing conditions this year to issue debt at levels not seen since the pandemic, adding cash to the balance sheet to pay for future refinancing needs and other projects.  Underpinning the surge in debt issuance: credit spreads, a metric that finance chiefs watch when deciding when to pull the trigger on a bond sale.  Whether debt issuance remains as strong in 2025 will depend in part on whether spreads remain attractive, advisers said.",
    "url": "https://finnhub.io/api/news?id=c4f4274a1b7c6327df1db70619f1d96e9d523196e58a58ed841f02f73d1b778f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735554600,
      "headline": "Credit Spreads Haven’t Looked This Good Since the 2000s. Can They Get Better?",
      "id": 132203088,
      "image": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Companies took advantage of favorable financing conditions this year to issue debt at levels not seen since the pandemic, adding cash to the balance sheet to pay for future refinancing needs and other projects.  Underpinning the surge in debt issuance: credit spreads, a metric that finance chiefs watch when deciding when to pull the trigger on a bond sale.  Whether debt issuance remains as strong in 2025 will depend in part on whether spreads remain attractive, advisers said.",
      "url": "https://finnhub.io/api/news?id=c4f4274a1b7c6327df1db70619f1d96e9d523196e58a58ed841f02f73d1b778f"
    }
  },
  {
    "ts": null,
    "headline": "Is AbbVie Inc. (ABBV) the Best Dividend Growth Stock to Buy and Hold in 2025?",
    "summary": "We recently compiled a list of the 10 Best Dividend Growth Stocks to Buy and Hold in 2025. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend growth stocks. Dividend stocks had a challenging year in 2024 as investor interest largely shifted toward technology stocks. […]",
    "url": "https://finnhub.io/api/news?id=9856ae6c5c599604b87759446e4d11d22597705dad258273d0e571d80ad69a66",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735550360,
      "headline": "Is AbbVie Inc. (ABBV) the Best Dividend Growth Stock to Buy and Hold in 2025?",
      "id": 132204940,
      "image": "https://s.yimg.com/ny/api/res/1.2/m1YYSOl9HO_x0LHuYGlC8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Best Dividend Growth Stocks to Buy and Hold in 2025. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend growth stocks. Dividend stocks had a challenging year in 2024 as investor interest largely shifted toward technology stocks. […]",
      "url": "https://finnhub.io/api/news?id=9856ae6c5c599604b87759446e4d11d22597705dad258273d0e571d80ad69a66"
    }
  },
  {
    "ts": null,
    "headline": "Highest Quality Dividend Kings For 2025",
    "summary": "Only 11 Dividend Kings outperformed the S&P 500 during the last decade based on Total Return. Check out five Dividend Kings earn the rank of High Quality.",
    "url": "https://finnhub.io/api/news?id=1c0b00de721d7553945bb154bae3133c545887dcb0f2a5b92e87761100624b07",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735543800,
      "headline": "Highest Quality Dividend Kings For 2025",
      "id": 132201763,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182848694/image_1182848694.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Only 11 Dividend Kings outperformed the S&P 500 during the last decade based on Total Return. Check out five Dividend Kings earn the rank of High Quality.",
      "url": "https://finnhub.io/api/news?id=1c0b00de721d7553945bb154bae3133c545887dcb0f2a5b92e87761100624b07"
    }
  }
]